cyqualon has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Markaverich, BM; Rodriguez, MA; Shoulars, K; Thompson, T | 1 |
| Alejandro, MA; Markaverich, BM | 1 |
2 other study(ies) available for cyqualon and Cancer of Prostate
| Article | Year |
|---|---|
Regulation of cell cycle and RNA transcription genes identified by microarray analysis of PC-3 human prostate cancer cells treated with luteolin.
Topics: Acetylation; Binding, Competitive; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; Cyclohexanones; DNA-Directed RNA Polymerases; Down-Regulation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Growth Inhibitors; Histones; Humans; Luteolin; Male; Oligonucleotide Array Sequence Analysis; Polo-Like Kinase 1; Polymerase Chain Reaction; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Receptors, Estrogen; Transcription Factors, General; Up-Regulation | 2010 |
Type II [3H]estradiol binding site antagonists: inhibition of normal and malignant prostate cell growth and proliferation.
Topics: Administration, Oral; Animals; Body Weight; Cell Division; Cyclohexanones; Estradiol; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Organ Size; Prostate; Prostatic Neoplasms; Rats; Receptors, Estradiol; Seminal Vesicles; Testis; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |